Vident Investment Advisory’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,533
Closed -$925K 1243
2022
Q4
$925K Buy
13,533
+652
+5% +$41.4K 0.03% 512
2022
Q3
$669K Sell
12,881
-769
-6% -$46K 0.02% 698
2022
Q2
$855K Buy
13,650
+889
+7% +$54.5K 0.03% 672
2022
Q1
$821K Buy
+12,761
New +$873K 0.02% 771
2015
Q4
Sell
-25,057
Closed -$412K 434
2015
Q3
$412K Buy
25,057
+5,126
+26% +$99.6K 0.06% 608
2015
Q2
$407K Buy
19,931
+1,175
+6% +$23.7K 0.05% 612
2015
Q1
$346K Buy
+18,756
New +$355K 0.07% 597

Other funds holding BRKR

Vident Investment Advisory's BRKR Position: Q1 2023 in Review

Vident Investment Advisory sold out of Bruker (BRKR) in Q1 2023, closing a stake of 13,533 shares — an estimated $925K sold.

Vident Investment Advisory first reported a position in BRKR in Q1 2015 and held it in 7 quarters. The position peaked at $925K in Q4 2022. 319 funds tracked by Wall St. Rank hold BRKR as of Q1 2023.

  • Vident Investment Advisory reported no remaining Bruker position as of Q1 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 13,533 Bruker shares in Q1 2023, an estimated $925K.
  • Vident Investment Advisory first reported a position in Bruker in Q1 2015 and held it in 7 quarters.
  • Vident Investment Advisory's Bruker position peaked at $925K in Q4 2022.
  • 319 funds tracked by Wall St. Rank held Bruker as of Q1 2023.

Based on Vident Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.